Reaction

Acute Graft Versus Host Disease In Skin reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 2,724 reports · 109 co-occurring drugs

As of the last recalculation, Acute Graft Versus Host Disease In Skin appears in 2,724 FAERS reports alongside 109 co-occurring drug terms. The strongest observed disproportionality signal is THIOTEPA (PRR 428.8).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.

Drug	Co-reports	PRR	ROR
Thiotepa	448	428.8	450.0
Fludarabine Phosphate	1,138	379.1	390.4
Busulfan	585	361.5	375.5
Anti-Thymocyte Globulin (Rabbit)	223	230.0	236.5
Melphalan Hydrochloride	341	118.7	120.3
Cyclosporine	1,017	110.9	111.9
Melphalan	289	108.5	109.9
Alemtuzumab	232	100.1	101.3
Mycophenolate Mofetil	1,046	94.9	95.6
Mycophenolate Mofetil Hydrochloride	1,046	94.7	95.5
Micafungin Sodium	98	91.6	92.6
Tacrolimus	961	71.9	72.3
Tacrolimus Ointment 0.1%	805	69.7	70.1
Tacrolimus Extended-Release Capsules	805	69.5	70.0
Ganciclovir Sodium	92	68.7	69.3
Ganciclovir	85	65.5	66.0
Sirolimus	104	61.3	61.8
Cyclophosphamide Injection, Solution	871	54.8	55.1
Cyclophosphamide	871	54.8	55.1
Cyclophosphamide For Injection	871	54.8	55.1
Posaconazole Delayed-Release	68	48.5	48.8
Blinatumomab	63	47.2	47.5
Itraconazole	63	42.2	42.4
Amphotericin B	60	37.4	37.6
Basiliximab	56	37.1	37.3
Voriconazole Injection	101	36.9	37.0
Posaconazole	76	36.7	36.9
Cytarabine	230	31.9	32.0
Ursosiol	76	30.7	30.8
Methylprednisolone	450	29.6	29.7
Voriconazole	111	29.1	29.2
Mesna Injection	30	28.0	28.1
Ursodiol	77	27.8	27.9
Mesna	30	27.5	27.6
Filgrastim	125	26.6	26.7
Azacitidine For	60	25.8	25.8
Granisetron Hydrochloride	31	22.9	23.0
Mycophenilic Acid	58	21.8	21.9
Methotrexate	826	21.1	21.1
Hydrocortisone Sodium Succinate	25	20.5	20.6
Methotrexate Sodium	866	19.5	19.5
Azacitidine	73	19.3	19.3
Etoposide	167	18.4	18.5
Cefepime Hydrochloride	35	16.8	16.8
Methylprednisolone Sodium Succinate	95	16.2	16.2
Fluconazole	137	15.7	15.7
Mycophenolic Acid	60	14.6	14.6
Prednisolone	302	14.3	14.3
Prednisolone Oral	302	14.3	14.3
Prednisolone Oral Solution	302	14.3	14.3
Acyclovir	197	14.1	14.2
Bendamustine Hcl	28	13.9	14.0
Polatuzumab Vedotin	17	13.4	13.4
Valganciclovir	32	13.1	13.1
Valganciclovir Hydrochloride	32	13.1	13.1
Ruxolitinib	118	13.1	13.1
Dalteparin Sodium	18	13.1	13.1
Anakinra	28	13.0	13.0
Meropenem	48	11.6	11.6
Atovaquone	12	11.4	11.5
Canakinumab	16	11.4	11.4
Piperacillin Sodium,Tazobactam Sodium	38	11.1	11.1
Magnesium Sulfate In Water For	18	10.8	10.8
Valganciclovir Hydrochloride Powder,	17	10.7	10.7
Magnesium Sulfate Heptahydrate	18	10.6	10.6
Magnesium Sulfate	18	10.6	10.6
Imatinib	22	9.6	9.6
Piperacillin Sodium And Tazobactam Sodium	23	9.0	9.0
Hydroxyurea	24	8.7	8.7
Prednisolone Acetate	11	8.2	8.2
Indomethacin	14	8.1	8.1
Cefepime	15	8.0	8.0
Cladribine	10	8.0	8.0
Rituximab	195	7.5	7.5
Vancomycin Hydrochloride	62	7.3	7.3
Piperacillin And Tazobactam	12	7.2	7.2
Romiplostim	14	7.1	7.1
Mercaptopurine	16	7.1	7.1
Levofloxacin	54	7.0	7.0
Levofloxacin In 5% Dextrose	54	7.0	7.0
Ifosfamide	19	6.8	6.8
Brentuximab Vedotin	9	6.7	6.7
Budesonide	51	6.7	6.7
Sorafenib	18	6.7	6.7
Vancomycin	49	6.6	6.6
Trimethoprim	10	6.5	6.5
Valacyclovir	33	6.1	6.1
Thalidomide	28	5.9	5.9
Granisetron	8	5.8	5.8
Tretinoin	6	5.7	5.7
Sulfamethoxazole And Trimethoprim	60	5.5	5.5
Daspone	7	5.5	5.5
Dapsone Gel, 5%	7	5.5	5.5
Adalimumab-Fkjp	32	5.3	5.3
Adalimumab-Aaty	32	5.2	5.2
Clobetasol Propionate Ointment Usp, 0.05%	7	5.2	5.2
Clobetasol Propionate	7	5.2	5.2
Dapsone	7	5.0	5.0
Phenytoin	13	4.8	4.8
Hydroxyzine Hydrochloride	8	4.7	4.7
Hydroxyzine Hydrochloride Oral	8	4.7	4.7
Dexamethasone Sodium Phosphate	6	4.5	4.5
Venetoclax	36	4.5	4.5
Heparin Sodium	8	4.5	4.5
Amikacin	9	4.0	4.0
Eculizumab	21	3.0	3.0
Eltrombopag Olamine	8	2.7	2.7
Abatacept	46	2.6	2.6
Bendamustine Hydrochloride	4	2.6	2.6

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.